Leptin consumption in the inflamed joints of patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 62, Issue 10, 2003, Pages 952-956

  Bokarewa, M ^a,b   Bokarew, D ^b   Hultgren, O ^b   Tarkowski, A ^b  

^a Dept Rheumatology/Inflammation Res ^*  (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; GLUCOCORTICOID; LEPTIN; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; SYNOVIAL FLUID;

EID: 0141762514     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.10.952     Document Type: Article

References (33)

1. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5.
2. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, et al. Congenital leptin deficiency is associated with severe early, onset obesity in humans. Nature 1997;387:903-8.
3. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 2001;15:2565-71.
4. Reseland J, Gordeladze J. Role of leptin in bone growth: central player or peripheral supporter? FEBS Lett 2002;528:40-9.
5. Juge-Aubry C, Meier C. Immunomodulatory actions of leptin. Mol Cell Endocrinol 2002;194:1-7.
6. Figenschau Y, Knutsen G, Shahazeydi S, Johansen O, Sveinbjornsson B. Human articular chondrocytes express functional leptin receptors. Biochem Biophys Res Commun 2001;287:190-7.
7. Maor G, Rochwerger M, Segev Y, Phillip M. Leptin acts as a growth factor on the chondrocytes of skeletal growth centers. J Bone Miner Res 2002;17:1034-43.
8. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, et al. Biological action of leptin as an angiogenic factor. Science 1998;281:1683-6.
9. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A, et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 2001;167:4593-9.
10. Gabay C, Dreyer M, Pellegrinelli N, Chicheportiche R, Meier CA. Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 2001;86:783-91.
11. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999;276:R136-42.
12. Hultgren OH, Tarkowski A. Leptin in septic arthritis:decreased levels during infection and amelioration of disease activity upon its administration. Arthritis Res 2001;3:389-94.
13. Arnalich F, Lopez J, Codoceo R, Jimnez M, Madero R, Montiel C. Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock. J Infect Dis 1999;180:908-11.
14. Morand EF, Leech M. Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis. Immunol Cell Biol 2001;79:395-9.
15. Wahle M, Krause A, Pierer M, Hantzschel H, Baerwald CG. Immunopathogenesis of rheumatic diseases in the context of neuroendocrine interactions. Ann N Y Acad Sci 2002;966:355-64.
16. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-2.
17. Ng PC, Lam CW, Lee CH, Fok TF, Chan IH, Ma KC, et al. Changes in serum leptin concentration after corticosteroid treatment in preterm infants. Acta Paediatr 2002;91:684-90.
18. Udden J, Bjorntorp P, Arner P, Barkeling B, Meurling L, Rossner S. Effects of glucocorticoids on leptin levels and eating behaviour in women. J Intern Med 2003;253:225-31.
19. Busso N, So A, Chobaz-Peclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 2002;168:875-82.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
21. Cohen S, Hurd E, Cush J, Schiff M, Weinblatt ME, Moreland LW, et al. Treatment of rheumatoid arthritis with anakinra a recombinant human interleukin-1 receptor antagonist in combination with methotrexate: results of a twenty-four-week multicenter randomized double-blind placebo-controlled trial. Arthritis Rheum 2002;46:614-24.
22. Glasow A, Kiess W, Anderegg U, Berthold A, Bottner A, Kratzsch J. Expression of leptin (Ob) and leptin receptor (Ob-R) in human fibroblasts: regulation of leptin secretion by insulin. J Clin Endocrinol Metab 2001;86:4472-9.
23. Bruun JM, Pedersen SB, Kristensen K, Richelsen B. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 2002;190:91-9.
24. Finck BN, Johnson RW. Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-alpha. Am J Physiol Regul Integr Comp Physiol 2002;282:R1429-35.
25. Longo-Sorbello GS, Bertino JR. Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. Haematologica 2001;86:121-7.
26. Ruggiero A, Conter V, Milani M, Biagi E, Lazzareschi I, Sparano P, et al. Intrathecal chemotherapy with antineoplastic agents in children. Paediatr Drugs 2001;3:237-46.
27. Besnard F, Even Y, Itier V, Granger P, Partiseti M, Avenet P, et al. Development of stable cell lines expressing different subtypes of GABAA receptors. J Recept Signal Transduct Res 1997;17:99-113.
28. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001;411:480-4.
29. Verrotti A, Basciani F, Morresi S, de Martino M, Morgese G, Chiarelli F. Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology 1999;53:230-2.
30. Pylvanen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojarvi JI. Serum insulin and leptin levels in valproate-associated obesity. Epilepsia 2002;43:514-17.
31. Fries JF, Spitz PW, Williams CA, Bloch DA, Singh G, Hubert HB. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum 1990;33:121-30.
32. van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ, et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week multicenter randomized double-blind placebo-controlled study. Arthritis Rheum 2001;44:1515-24.
33. Volek JS, Gomez AL, Love DM, Weyers AM, Hesslink R Jr, Wise JA, et al. Effects of an 8-week weight-loss program on cardiovascular disease risk factors and regional body composition. Eur J Clin Nutr 2002;56:585-92.